Tuesday, October 25

Day 3 of ASTRO's 64th Annual Meeting! Today’s Daily News features a video message from ASTRO Chair Laura Dawson, MD, FASTRO, coverage on Monday's programming, including the Plenary session and Presidents Address, expert commentary on abstracts presented at the meeting and previews what's in store for Day 3 and more!

The on-site Show Daily News includes a recap of the Presidential Address and Plenary, the day's schedule-at-a-glance, a repot from RO-ILS, a photo spread and much more! Be sure to pick up a copy from bins around the convention center if you are on site and view the pdf linked below.

Tuesday Show Daily Access the Tuesday Show Daily at the 2022 ASTRO Annual Meeting.

Tuesday Digital Daily Access the Digital Daily from day 3 at the 2022 ASTRO Annual Meeting.

Plenary session recap Plenary session studies explore artificial intelligence, radiation in combination with other therapies across five major disease sites

Presidential Address Monday afternoon, ASTRO President Geraldine Jacobson, MD, MPH, MBA, FASTRO, gave her Presidential Address, offering a forward-thinking message on how artificial intelligence (AI) and emotional intelligence (EI) can shape the future of radiation oncology. 

Keynote I Monday morning, Ruha Benjamin, PhD, gave a timely and thought-provoking keynote: Race to the Future? Reimagining the Default Settings of Technology and Society.

AI and Risk This Plenary session abstract discusses multi-modal artificial intelligence models and provides an important update on risk stratification for PCa patients.

Craniospatial RT Jonathan Yang, MD, PhD, et al. from Memorial Sloan-Kettering Cancer Center reported the results of a phase II randomized trial comparing proton craniospinal irradiation (pCSI) and photon involved-field radiotherapy (IFRT) for patients with leptomeningeal metastasis (LM) from non-small cell lung or breast carcinoma. 

SABR-5 Analysis The role of stereotactic ablative radiotherapy (SABR) in oligometastatic disease continues to evolve and the identification of which patients may benefit from SABR remains an ongoing clinical question.

RT for AFib Stereotactic body radiation therapy has been used to successfully treat ventricular tachycardia with a technique that has been referred to as STereotactic Arrhythmia Radioablation (STAR).